Patrick Blanc

Learn More
AIMS The choice of resynchronization therapy between with (CRT-D) and without (CRT-P) a defibrillator remains a contentious issue. Cause-of-death analysis among CRT-P, compared with CRT-D, patients could help evaluate the extent to which CRT-P patients would have additionally benefited from a defibrillator in a daily clinical practice. METHODS AND RESULTS(More)
Dear sir, Glatiramer acetate (GA) is an immunomodulator widely used for several years in the treatment of relapsing-remitting multiple sclerosis (MS) and usually considered as safe. We report a case of cytolytic hepatitis related to recent prescription of GA in a patient without any previous hep-atotoxic treatment and sign of hepatic autoimmunity. A(More)
  • 1